Ranitidine
Product Images NDC 71821-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 71821-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vkt Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B9878674 E349 4222 8dee B026f4f0c5b9 01)

Chemical structure of Ranitidine, depicting the molecular arrangement including a furan ring, thioether linkage, and nitroguanidine group, as represented in the molecular diagram.*

FDA Label Image

150 mg (B9878674 E349 4222 8dee B026f4f0c5b9 02)

Ranitidine Tablets, USP 150 mg label from VKT Pharma Private Limited. The label includes dosage strength, quantity of 500 tablets, and storage instructions. Manufacturer information and barcode are also shown. The design features a blue and yellow color scheme with the NDC 71821-001-01 displayed.*

FDA Label Image

300 mg (B9878674 E349 4222 8dee B026f4f0c5b9 03)

Ranitidine Tablets, USP 300 mg packaging label by VKT Pharma Private Limited. The label states 250 tablets per container, includes dosage information, storage instructions, and warnings. The label features the product name prominently, the strength as 300 mg, and the labeler details with address in Andhra Pradesh, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.